NVO - Why Novo Nordisk Shares Are Trading Higher Tuesday | Benzinga
Novo Nordisk (NYSE:NVO) stock is moving higher Tuesday following China’s approval of Novo’s weight loss drug, Wegovy.
What Happened: Wegovy has been approved in China, the second most populated country that is estimated to have the world’s highest number of overweight individuals, according to Reuters.
However, in China, Novo’s patent for one of the ...